XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 5 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $35,000 | -32.7% | 25,961 | 0.0% | 0.00% | – |
| Q2 2019 | $52,000 | -14.8% | 25,961 | 0.0% | 0.00% | – |
| Q1 2019 | $61,000 | +35.6% | 25,961 | 0.0% | 0.00% | – |
| Q4 2018 | $45,000 | -21.1% | 25,961 | 0.0% | 0.00% | – |
| Q3 2018 | $57,000 | +18.8% | 25,961 | 0.0% | 0.00% | – |
| Q2 2018 | $48,000 | +6.7% | 25,961 | 0.0% | 0.00% | – |
| Q1 2018 | $45,000 | -23.7% | 25,961 | 0.0% | 0.00% | – |
| Q4 2017 | $59,000 | -4.8% | 25,961 | 0.0% | 0.00% | – |
| Q3 2017 | $62,000 | -24.4% | 25,961 | 0.0% | 0.00% | – |
| Q2 2017 | $82,000 | +20.6% | 25,961 | 0.0% | 0.00% | – |
| Q1 2017 | $68,000 | – | 25,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Noked Israel Ltd | 198,888 | $179 | 0.05% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 40,571 | $36,417 | 0.00% |
| UBS Group AG | 120 | $108 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 300 | $269 | 0.00% |